Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.

Kelly, J D; Forster, A M; Higley, B; Archer, C M; Booker, F S; Canning, L R; Chiu, K W; Edwards, B; Gill, H K; McPartlin, M

Kelly, J D; Forster, A M; Higley, B; Archer, C M; Booker, F S; Canning, L R; Chiu, K W; Edwards, B; Gill, H K; McPartlin, M.

Affiliation

Kelly JD; Pharmaceuticals Research and Development, Amersham International plc, Buckinghamshire, United Kingdom.

J Nucl Med ; 34(2): 222-7, 1993 Feb.

Article in En | MEDLINE | ID: mdl-8429340

Subject(s)

Heart/diagnostic imaging; Organophosphorus Compounds/chemistry; Organotechnetium Compounds/chemistry; Animals; Chromatography, High Pressure Liquid; Female; Guinea Pigs; Male; Organophosphorus Compounds/toxicity; Organotechnetium Compounds/toxicity; Radionuclide Imaging; Rats; Rats, Wistar; Swine; Swine, Miniature; Tissue Distribution

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Organophosphorus Compounds / Organotechnetium Compounds / Heart Limits: Animals Language: En Journal: J Nucl Med Year: 1993 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links